Further, Cdk2ablation induced senescence in both pancreatic β-cells and hematopoieticB-cells after Myc activation, the latter correlating with delayed lymphoma development.This underscores that Cdk2 inhibitors should be reassessed as therapeuticagents, especially for Myc- or Ras-driven tumors. The gene discussed is MYC; the disease is lymphoma.